Hematology Analyzers Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Hematology Analyzer Companies and the market is Segmented by Product (Instruments, Reagents, and Services), End Users (Hospitals, Clinical Laboratories, Research Institutes, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Hematology Analyzers Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Hematology Analyzers Market Size

Hematology Analyzers Market Summary
Study Period 2021 - 2030
Market Size (2025) USD 6.67 Billion
Market Size (2030) USD 9.40 Billion
CAGR (2025 - 2030) 7.10 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Hematology Analyzers Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Hematology Analyzers Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Hematology Analyzers Market Analysis

The Hematology Analyzers Market size is estimated at USD 6.67 billion in 2025, and is expected to reach USD 9.40 billion by 2030, at a CAGR of 7.1% during the forecast period (2025-2030).

There was an increasing focus on the hematology parameters for the assessment of COVID-19 around the world. Various research studies published provide insight into the effects of the pandemic on the market. For instance, in April 2021, a study published in the National Library of Medicine stated that the ongoing COVID-19 pandemic had an impact on the laboratory hematology community. Nevertheless, the pace of COVID-19 hematology-related research has continued to accelerate and has established the role of laboratory hematology data for many purposes including disease prognosis and outcome. However, initiatives such as partnerships by key market players are expected to increase the market growth. For instance, in January 2021, F. Hoffmann-La Roche AG signed a global business partnership agreement with Sysmex Corporation that allows Roche to distribute Sysmex hematology testing products, including instruments and reagents. Thus, with such initiatives, the market is likely to grow over the forecast period.

The major factors for the growth of the hematology analyzers market include the rising burden of blood disorders, increasing technological advancements, and rising adoption rates of automated hematology instruments. Blood disorders have become a global health issue with different causes and are associated with high mortality. Blood disorders, such as anemia, blood cancers, hemorrhagic conditions, and infections in the blood, affect millions of people each year across all age groups. According to the Australian Government, Department of Health and Aged Care report in 2022, more than 330,000 affected infants are born each year (83% sickle cell disorders and 17% thalassaemias), around 7% of pregnant women are carriers of hemoglobin disorders, and over 1% of couples are at risk at a global level.

Similarly, according to the World Federation of Hemophilia report updated July 2022, more than 1,125,000 men worldwide have an inherited bleeding disorder, and 418,000 of those have a severe version of the most undiagnosed disease. Early diagnosis and treatment are the best ways to protect the quality of life of a patient with a blood cell disorder. Hence, the increasing burden of blood disorders is likely to drive the market in the future.

Product launches are another factor in market growth. For instance, in July 2022, CellaVision launched DIFF-Line. CellaVision DC-1 is a single-slide analyzer that automates and digitizes the process of analyzing peripheral blood smears. Thus, such product launches are expected to increase market growth over the forecast period.

However, the high cost of hematology analyzers and time-consuming and stringent regulatory policies associated with the same is restraining the overall market growth.

Hematology Analyzers Industry Overview

The hematology analyzers market is a fragmented market owing to the presence of various market players. Some of the market players are Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories, Boule Diagnostics AB, F Hoffmann-La Roche Ltd, Hobira Ltd, Nihon Kohden Corporation, Mindray Medical International Limited (Shenzhen Mindray Bio-Medical Electronics Co. Ltd), Siemens Healthineers, and Sysmex Corporation.

Hematology Analyzers Market Leaders

  1. Abbott Laboratories

  2. HORIBA Ltd

  3. Siemens Healthineers

  4. Sysmex Corporation

  5. Danaher Corporation

  6. *Disclaimer: Major Players sorted in no particular order
12.png
Need More Details on Market Players and Competiters?
Download PDF

Hematology Analyzers Market News

  • In May 2022, Nihon Kohden India established a new hematology analyzer reagent factory.
  • In March 2022, Mindray launched the BC-700 Series, a revolutionary hematology analyzer series that includes both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests. 

Hematology Analyzers Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Blood Disorders
    • 4.2.2 Increasing Technological Advancements and Rising Adoption Rates of Automated Hematology Instruments
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Hematology Analyzers
    • 4.3.2 Time-consuming and Stringent Rregulatory Policies
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers/Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Instruments
    • 5.1.1.1 3 Part Hematology Analyzer
    • 5.1.1.2 5 Part Hematology Analyzer
    • 5.1.1.3 Point-of-care Testing Hematology Analyzers
    • 5.1.1.4 Others
    • 5.1.2 Reagents
    • 5.1.3 Services
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Clinical Laboratories
    • 5.2.3 Research Institutes
    • 5.2.4 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Beckman Coulter Inc. (Danaher Corporation)
    • 6.1.3 Bio-Rad Laboratories
    • 6.1.4 Boule Diagnostics AB
    • 6.1.5 F Hoffmann-La Roche Ltd
    • 6.1.6 Horiba Ltd
    • 6.1.7 Nihon Kohden Corporation
    • 6.1.8 Siemens Healthineers
    • 6.1.9 Sysmex Corporation
    • 6.1.10 Stratec Biomedical Systems (DIATRON)
    • 6.1.11 Ortho Clinical Diagnostics
    • 6.1.12 Accurex Biomedical Pvt. Ltd.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Hematology Analyzers Industry Segmentation

As per the scope of this report, hematology analyzers are the equipment used to run tests on blood samples, and they are used in the medical field to determine white blood cell counts, complete blood counts, reticulocyte analysis, and coagulation tests. The Hematology Analyzers market is Segmented by Product (Instruments, Reagents, and Services), End Users (Hospitals, Clinical Laboratories, Research Institutes, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Type Instruments 3 Part Hematology Analyzer
5 Part Hematology Analyzer
Point-of-care Testing Hematology Analyzers
Others
Reagents
Services
By End User Hospitals
Clinical Laboratories
Research Institutes
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Hematology Analyzers Market Research FAQs

How big is the Hematology Analyzers Market?

The Hematology Analyzers Market size is expected to reach USD 6.67 billion in 2025 and grow at a CAGR of 7.10% to reach USD 9.40 billion by 2030.

What is the current Hematology Analyzers Market size?

In 2025, the Hematology Analyzers Market size is expected to reach USD 6.67 billion.

Who are the key players in Hematology Analyzers Market?

Abbott Laboratories, HORIBA Ltd, Siemens Healthineers, Sysmex Corporation and Danaher Corporation are the major companies operating in the Hematology Analyzers Market.

Which is the fastest growing region in Hematology Analyzers Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Hematology Analyzers Market?

In 2025, the North America accounts for the largest market share in Hematology Analyzers Market.

What years does this Hematology Analyzers Market cover, and what was the market size in 2024?

In 2024, the Hematology Analyzers Market size was estimated at USD 6.20 billion. The report covers the Hematology Analyzers Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Hematology Analyzers Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Hematology Analyzer Industry Report

Statistics for the 2025 Hematology Analyzers market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Hematology Analyzers analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.